Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
Healthcare
$27.69 +1.77%
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
52W Low $24.15High $32.23
Volume 0.40M
Average 0.51M
AVLN Debt Repayment
Cash used to repay borrowings during the period.
No reported Debt Repayment figures are available to summarize.
Debt Repayment history
Currency unavailable · from the cash flow
No Debt Repayment data reported for this period type.
Debt Repayment vs competitors
How AVLN compares with its peers on the latest reported figures
AVLN Competitors
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $288.79M USD | +324.8% | — | 80.0% | |
| LTM Jun 2026 | $3.15M USD | -102.2% | — | 0.3% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
VCREVicore Pharma Holding AB | LTM Jun 2026 | SEK 0 SEK | — | — | 0.0% |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding AVLN) | — | +111.3% | — | 0.1% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Currency unavailable
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.